Home/Pipeline/Next-Generation Intravascular Lithotripsy (IVL)

Next-Generation Intravascular Lithotripsy (IVL)

Complex Calcified Lesions (Coronary/Peripheral)

DevelopmentActive

Key Facts

Indication
Complex Calcified Lesions (Coronary/Peripheral)
Phase
Development
Status
Active
Company

About Vantis Vascular

Vantis Vascular is a clinical-stage medical device innovator targeting the high-growth market for complex vascular interventions. The company's core technology is the CrossFast™ system, a dual-catheter delivery platform engineered to navigate challenging anatomies, with the potential to reduce complications and increase procedural efficiency. Founded by physicians, Vantis is leveraging its platform to develop next-generation solutions, including an intravascular lithotripsy (IVL) system and specialized peripheral (BTK) devices. With a seasoned leadership team experienced in vascular device startups and exits, the company is positioned to address significant unmet needs in interventional cardiology and vascular medicine.

View full company profile